Basel Medical Group Prices IPO At $4.00 Per Share, Raising $8.82Mln; Stock Down

February 26, 2025 — 12:32 pm EST

Written by RTTNews.com for RTTNews

(RTTNews) - Basel Medical Group Ltd (BMGL), a leading provider of orthopedic and neurosurgical services, Wednesday announced the pricing of its initial public offering or IPO, raising approximately US$8.82 million.

The company is offering 2.205 million ordinary shares at a price of $4.00 per share. The shares are expected to begin trading on the Nasdaq Capital Market under the ticker 'BMGL' on February 25, 2025.

The funds from this offering will be used to support potential mergers and acquisitions, business expansion, including increasing clinic space and enhancing service capabilities, as well as bolstering daily operations and working capital.

Additionally, the company has granted underwriters a 45-day option to purchase up to 330,750 additional shares.

The offering is expected to close on February 26, 2025.

Currently, BMGL is trading at $4.10, down 7.66 percent on the Nasdaq.

RTTNews

Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.

Basel Medical Group Prices IPO At $4.00 Per Share, Raising $8.82Mln; Stock Down

Tags

Latest Articles